These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 22800120)

  • 1. Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naïve schizophrenia patients after treatment with risperidone.
    Cai HL; Li HD; Yan XZ; Sun B; Zhang Q; Yan M; Zhang WY; Jiang P; Zhu RH; Liu YP; Fang PF; Xu P; Yuan HY; Zhang XH; Hu L; Yang W; Ye HS
    J Proteome Res; 2012 Aug; 11(8):4338-50. PubMed ID: 22800120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action.
    Xuan J; Pan G; Qiu Y; Yang L; Su M; Liu Y; Chen J; Feng G; Fang Y; Jia W; Xing Q; He L
    J Proteome Res; 2011 Dec; 10(12):5433-43. PubMed ID: 22007635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomic study of biochemical changes in the plasma and urine of primary dysmenorrhea patients using UPLC-MS coupled with a pattern recognition approach.
    Su S; Duan J; Wang P; Liu P; Guo J; Shang E; Qian D; Tang Y; Tang Z
    J Proteome Res; 2013 Feb; 12(2):852-65. PubMed ID: 23290075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal plasma monoamine metabolism in schizophrenia and its correlation with clinical responses to risperidone treatment.
    Cai HL; Fang PF; Li HD; Zhang XH; Hu L; Yang W; Ye HS
    Psychiatry Res; 2011 Jul; 188(2):197-202. PubMed ID: 21146875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolomic mapping of atypical antipsychotic effects in schizophrenia.
    Kaddurah-Daouk R; McEvoy J; Baillie RA; Lee D; Yao JK; Doraiswamy PM; Krishnan KR
    Mol Psychiatry; 2007 Oct; 12(10):934-45. PubMed ID: 17440431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophrenia.
    Lane CJ; Ngan ET; Yatham LN; Ruth TJ; Liddle PF
    J Psychiatry Neurosci; 2004 Jan; 29(1):30-7. PubMed ID: 14719048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma γ-aminobutyrate/glutamate ratio and responses to risperidone antipsychotic treatment in schizophrenia.
    Cai HL; Zhu RH; Li HD; Zhang XH; Hu L; Yang W; Ye HS
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1273-8. PubMed ID: 20637820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug.
    Glenthoj A; Glenthoj BY; Mackeprang T; Pagsberg AK; Hemmingsen RP; Jernigan TL; Baaré WF
    Psychiatry Res; 2007 Apr; 154(3):199-208. PubMed ID: 17360162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects of risperidone on spatial working memory in first-episode schizophrenia.
    Reilly JL; Harris MS; Keshavan MS; Sweeney JA
    Arch Gen Psychiatry; 2006 Nov; 63(11):1189-97. PubMed ID: 17088499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
    Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
    Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia.
    Murashita M; Inoue T; Kusumi I; Nakagawa S; Itoh K; Tanaka T; Izumi T; Hosoda H; Kangawa K; Koyama T
    Psychiatry Clin Neurosci; 2007 Feb; 61(1):54-8. PubMed ID: 17239039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells.
    Liu ML; Zheng P; Liu Z; Xu Y; Mu J; Guo J; Huang T; Meng HQ; Xie P
    Mol Biosyst; 2014 Jul; 10(9):2398-406. PubMed ID: 24975926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
    Kopala LC; Fredrikson D; Good KP; Honer WG
    Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
    [No Abstract]   [Full Text] [Related]  

  • 14. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
    Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
    Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased plasma antioxidants in schizophrenia.
    Pae CU; Paik IH; Lee C; Lee SJ; Kim JJ; Lee CU
    Neuropsychobiology; 2004; 50(1):54-6. PubMed ID: 15179021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study.
    Nakano Y; Yoshimura R; Nakano H; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Ueda N; Nakamura J
    Hum Psychopharmacol; 2010 Mar; 25(2):139-44. PubMed ID: 20196178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities in visually guided saccades suggest corticofugal dysregulation in never-treated schizophrenia.
    Reilly JL; Harris MS; Keshavan MS; Sweeney JA
    Biol Psychiatry; 2005 Jan; 57(2):145-54. PubMed ID: 15652873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MultiSimplex optimization of chromatographic separation and dansyl derivatization conditions in the ultra performance liquid chromatography-tandem mass spectrometry analysis of risperidone, 9-hydroxyrisperidone, monoamine and amino acid neurotransmitters in human urine.
    Cai HL; Zhu RH; Li HD; Zhang J; Li LF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1993-9. PubMed ID: 21621490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma brain-derived neurotropic factor, not nerve growth factor-Beta, in schizophrenia patients with better response to risperidone treatment.
    Lee BH; Kim YK
    Neuropsychobiology; 2009; 59(1):51-8. PubMed ID: 19270464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of risperidone on glucose metabolism in Chinese patients with schizophrenia: a prospective study.
    Chen Q; Cai ZJ; Mao PX; Zhai YM; Mitchell PB; Tang YL
    J Psychiatr Res; 2008 Dec; 43(2):124-8. PubMed ID: 18423490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.